Presence of CD133‐positive circulating tumor cells predicts worse progression‐free survival in patients with metastatic castration‐sensitive prostate cancer

Objective To investigate the clinical significance of the expression of the stemness marker CD133 in circulating tumor cells of newly diagnosed metastatic castration‐sensitive prostate cancer patients. Methods For this study, 104 metastatic castration‐sensitive prostate cancer patients treated at th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of urology 2022-05, Vol.29 (5), p.383-389
Hauptverfasser:	Yang, Yunjie, Liu, Zheng, Wang, Qifeng, Chang, Kun, Zhang, Junyu, Ye, Dingwei, Kong, Yunyi, Dai, Bo
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - therapeutic use Androgens Androgens - therapeutic use Biomarkers, Tumor Castration CD133 China circulating tumor cells Humans Male Mesenchyme Metastases Metastasis Neoplastic Cells, Circulating - metabolism Neoplastic Cells, Circulating - pathology Original : Clinical Investigation Patients Prognosis Progression-Free Survival Prostate cancer Prostatic Neoplasms, Castration-Resistant time to castration resistance Tumor cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!